Latest GM & Biosafety Resources

UPDATE: After nine years of arduous litigation by the ACB, a full bench of the Supreme Court of Appeal on 22 October 2024 set aside several layers of decision-making regarding the approval of the application by Monsanto, now Bayer, for commercial release of its drought-tolerant genetically modified maize, MON87460. 28 June 2023 UPDATE: In 2023, […]

International and national biosafety regulations are urgently needed, including the right to say no By Sabrina Masinjila, African Centre for Biodiversity (ACB) research and advocacy officer Masinjila can be seen making a statement on behalf of the Convention of Biological Diversity Alliance (CBDA), calling for Parties to support the ongoing work of the Multidisciplinary Ad […]

 Dear friends and colleagues, The ACB, supported by 18 organisations/networks in South Africa, has made a substantive submission to the Registrar of the Fertilizers, Farm Feeds, Seeds and Remedies Act 36 of 1947 (commonly referred to as Act 36), to institute a review in terms of section 4 of the Act 36, into the continued […]

– By ACB Research and Advocacy Officer Sabrina Masinjila & Executive Director Mariam Mayet For several years, the ACB has engaged at multiple levels with the development of the Post-2020 Global Biodiversity Framework (GBF). In the lead up to the Convention on Biological Diversity (CBD) Conservation’s fifteenth Conference of Parties (COP 15), held in Montreal, Canada in […]

– A blog by ACB Director Mariam Mayet Snapshot In October 2021, the South African (SA) government determined that the regulatory and risk assessment framework that exists for genetically modified organisms (GMOs) will also apply to new breeding techniques (NBTs), which make up a host of new genetic engineering technologies. This decision appears to follow […]

The endless extensions to the State of Disaster, initially declared two years ago, has provoked criticism from medical experts and calls for its end from public-interest groups and an increasingly fed-up citizenry. Recently, the government announced that the restrictions were finally to be lifted.  However, during this time, a draft amendment to the National Health […]

(Veuillez cliquer ici pour lire en français) The African Centre for Biodiversity (ACB) hereby publishes a new research paper, titled, “The Financialisation of malaria: Burkina Faso, Rogue capital & GM/gene drive mosquitoes.” This paper seeks to understand the financialisation of malaria as a vehicle for rogue capital in a context of a weakened state (through […]

Southern African civil society responds to false claims about benefits to food and nutrition security The African Centre of Biodiversity joins a collective of civil society organisations to endorse Glen Ashton’s calling out of chief economist of AgBiz, Wandile Sihlobo, on his May articles in Business Day and Project Syndicate, which promote the continued use […]

In a totally unexpected move, the newly appointed Tanzania Agricultural Minister, Prof Adolf Mkenda, in mid-January 2021 announced the cancellation of research trials involving genetically modified organisms (GMOs) in the country and the decision to put in place extra biosafety scrutiny of imported genetically modified (GM) seed. The decision was taken by the Minister in […]

An unproven genetically modified (GM) RNAi cassava variety is yet another staple food crop, after maize and banana, on the biotech industry’s agenda for commercial cultivation in Kenya. The brazen lack of safety tests contained in the Kenya Agricultural and Livestock Research Organisation’s (KARLO’s) application for cultivation, and disregard for adherence to biosafety best practise […]

Clique aqui para a versão portuguesa Por favor, haga clic aquí para el español The African Centre for Biodiversity (ACB) has made a submission to the Registrar of GMOs in South Africa, following an application made by Professor Shabir Ahmed Madhi, from the Respiratory and Meningeal Pathogens Research Unit (RMPRU), Chris Hani Baragwanath Academic Hospital, […]

On Monday 1st July 2019, Target Malaria announced the release of 6400 genetically modified (GM) sterile male mosquitoes in Bana, a village in Burkina Faso – the first GM insects to be released in Africa. This is Phase I – by Phase III, Target Malaria aims to release gene drive mosquitoes. Gene drives are based […]